Chandler, Arizona Clinical Trials

A listing of Chandler, Arizona clinical trials actively recruiting patient volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 34 clinical trials
Infigratinib in Recurrent Glioblastoma Patients

This trial is an open-label, multicenter, Phase 0 trial that will enroll up to 20 participants with recurrent high-grade glioma with FGFR1 K656E or FGFR3 K650E mutation or FGFR3-TACC3 translocation which are scheduled for resection. In the lead-in cohort, a total of 20 participants will be enrolled into the proposed …

glioblastoma multiforme
temozolomide
infigratinib
recurrent malignant glioma
recurrent glioblastoma
Chandler Regional Medical Center
 (2.4 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +2 other locations
PTI-125 100 mg for Mild-to-moderate Alzheimer's Disease Patients

An Open-label study for patients who completed the previous studies, PTI-125-02 or PTI-125-03. Additional new patients will be included for a total of 100 patients enrolled for this study.

mini-mental state examination
galantamine
alzheimer's disease
amyloidosis
dementia
Cognitive Clinical Trials
 (6.2 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +8 other locations
DELIVER Study in a Population With Clinical Suspicion of Liver Cirrhosis (DELIVER)

Owlstone Medical has demonstrated that the use of an Exogenous Volatile Organic Compound (EVOC) that targets specific metabolic processes linked to cirrhosis pathophysiology enables identification of subjects with cirrhosis with high accuracy compared to healthy controls. This approach relies on the oral administration of food additives that are metabolized in …

Arizona Liver Health
 (0.2 away) Contact site
  • 0 views
  • 25 Jun, 2025
  • +2 other locations
Registry of Asthma Patients Initiating DUPIXENT

The primary objective of the study is to characterize the patients who initiate treatment for asthma with DUPIXENT in a real-world setting. The secondary objectives of the study are: To characterize real-world use patterns of DUPIXENT for asthma To assess the long-term effectiveness of DUPIXENT in asthma patients in a …

Regeneron Study Site
 (6.7 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • 1 location